IL220164B - A method for purifying a purified antibody, antibody fragment, or fc-fused protein using an affinity chromatography matrix - Google Patents

A method for purifying a purified antibody, antibody fragment, or fc-fused protein using an affinity chromatography matrix

Info

Publication number
IL220164B
IL220164B IL220164A IL22016412A IL220164B IL 220164 B IL220164 B IL 220164B IL 220164 A IL220164 A IL 220164A IL 22016412 A IL22016412 A IL 22016412A IL 220164 B IL220164 B IL 220164B
Authority
IL
Israel
Prior art keywords
fusion protein
antibody
affinity chromatography
chromatography matrix
producing purified
Prior art date
Application number
IL220164A
Other languages
English (en)
Hebrew (he)
Other versions
IL220164A0 (en
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43598315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL220164(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL220164A0 publication Critical patent/IL220164A0/en
Publication of IL220164B publication Critical patent/IL220164B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804Affinity chromatography
    • B01D15/3809Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL220164A 2009-12-18 2012-06-04 A method for purifying a purified antibody, antibody fragment, or fc-fused protein using an affinity chromatography matrix IL220164B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28805909P 2009-12-18 2009-12-18
PCT/EP2010/070076 WO2011073389A1 (en) 2009-12-18 2010-12-17 Wash solution and method for affinity chromatography

Publications (2)

Publication Number Publication Date
IL220164A0 IL220164A0 (en) 2012-07-31
IL220164B true IL220164B (en) 2019-02-28

Family

ID=43598315

Family Applications (1)

Application Number Title Priority Date Filing Date
IL220164A IL220164B (en) 2009-12-18 2012-06-04 A method for purifying a purified antibody, antibody fragment, or fc-fused protein using an affinity chromatography matrix

Country Status (18)

Country Link
US (3) US9505803B2 (OSRAM)
EP (2) EP3272764B1 (OSRAM)
JP (2) JP5909450B2 (OSRAM)
KR (1) KR101858266B1 (OSRAM)
CN (1) CN102725304B (OSRAM)
AU (1) AU2010332778B2 (OSRAM)
BR (1) BR112012014937B1 (OSRAM)
CA (1) CA2784278C (OSRAM)
DK (2) DK3272764T3 (OSRAM)
ES (2) ES2982297T3 (OSRAM)
IL (1) IL220164B (OSRAM)
LT (2) LT3272764T (OSRAM)
MX (1) MX2012007103A (OSRAM)
PL (2) PL3272764T3 (OSRAM)
PT (2) PT2513134T (OSRAM)
RU (1) RU2564569C2 (OSRAM)
SG (2) SG10201408384PA (OSRAM)
WO (1) WO2011073389A1 (OSRAM)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2500413A1 (en) 2006-09-13 2012-09-19 Abbott Laboratories Cell culture improvements
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
JP5808249B2 (ja) 2008-10-20 2015-11-10 アッヴィ・インコーポレイテッド プロテインaアフィニティークロマトグラフィーを用いる抗体の単離および精製
SG10201702951RA (en) 2008-10-20 2017-06-29 Abbvie Inc Viral inactivation during purification of antibodies
PL3272764T3 (pl) * 2009-12-18 2024-06-10 Novartis Ag Sposób chromatografii powinowactwa
JP5567691B2 (ja) * 2010-01-22 2014-08-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Fc含有タンパク質を精製するためのクロマトグラフィー法
WO2012164046A1 (en) * 2011-06-01 2012-12-06 Novartis Ag Wash solution and method for affinity chromatography
KR102492792B1 (ko) 2011-10-11 2023-01-30 제넨테크, 인크. 이중특이적 항체의 개선된 어셈블리
CA2910065C (en) * 2013-05-15 2023-09-19 Medimmune Limited Purification of recombinantly produced polypeptides
EP3041593B1 (en) * 2013-09-05 2025-01-29 F. Hoffmann-La Roche AG Method of cleaning a chromatography material for its reuse
US9546208B2 (en) 2014-01-03 2017-01-17 Bio-Rad Laboratories, Inc. Removal of impurities from protein A eluates
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
EA035635B1 (ru) 2015-03-13 2020-07-17 Бристол-Маерс Сквибб Компани Использование щелочных промывочных растворов во время хроматографии для удаления примесей
CN107849122B (zh) * 2015-08-21 2022-01-25 豪夫迈·罗氏有限公司 用低电导率洗涤缓冲液进行亲和层析纯化
AU2016312909B2 (en) 2015-08-21 2022-12-08 F. Hoffmann-La Roche Ag Method for the reduction of host cell proteins in affinity chromatography
US11753438B2 (en) 2016-05-11 2023-09-12 Cytiva Bioprocess R&D Ab Method of cleaning and/or sanitizing a separation matrix
JP7031934B2 (ja) 2016-05-11 2022-03-08 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックス
US10513537B2 (en) 2016-05-11 2019-12-24 Ge Healthcare Bioprocess R&D Ab Separation matrix
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
JP7106187B2 (ja) 2016-05-11 2022-07-26 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックスを保存する方法
ES2994244T3 (en) * 2016-07-25 2025-01-21 Cephalon Llc Affinity chromatography wash buffer
US12448411B2 (en) 2016-09-30 2025-10-21 Cytiva Bioprocess R&D Ab Separation method
CN111344410B (zh) 2017-08-17 2023-09-15 济世易为生物有限公司 从宿主细胞半乳糖凝集素和其他污染物中纯化糖基化蛋白的方法
CN107793469B (zh) * 2017-10-16 2021-07-30 上海药明生物技术有限公司 一种去除宿主细胞蛋白含量的亲和纯化工艺
EP3728288B1 (en) * 2017-12-21 2022-01-19 Genzyme Corporation Methods for enhanced removal of impurities during protein a chromatography
CN119881293A (zh) 2018-03-21 2025-04-25 沃特世科技公司 基于非抗体高亲和力的样品制备、吸附剂、装置和方法
US11407838B2 (en) 2018-04-02 2022-08-09 Amgen Inc. Erenumab compositions and uses thereof
CN112105927B (zh) * 2018-05-08 2024-06-25 沃特世科技公司 可用于pH梯度阳离子交换色谱法的方法、组合物和试剂盒
WO2021072005A1 (en) * 2019-10-08 2021-04-15 North Carolina State University Immunoglobulin purification peptides and their use
CA3176109A1 (en) * 2020-03-27 2021-09-30 Haemalogix Pty Ltd Composition and method
JP2023523324A (ja) * 2020-04-27 2023-06-02 アレクシオン ファーマシューティカルズ, インコーポレイテッド 抗体のプロテインaクロマトグラフィー精製
CN112827217A (zh) * 2020-12-29 2021-05-25 苏州良辰生物医药科技有限公司 一种层析柱清洗液及其应用
KR20250121073A (ko) * 2022-12-12 2025-08-11 하. 룬드벡 아크티에셀스카브 단백질 정제에서 아르기닌 세척
WO2024233992A2 (en) * 2023-05-11 2024-11-14 Trophogen, Inc. Methods of manufacturing highly glycosylated glycoprotein hormones and their analogs

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704366A (en) 1984-06-22 1987-11-03 Bio-Rad Laboratories, Inc. Process for binding IgG to protein A
US4857320A (en) * 1987-02-19 1989-08-15 Monsanto Company Method of enhancing the solubility of tissue plasminogen activator
JPH01238534A (ja) * 1988-03-17 1989-09-22 Mitsui Toatsu Chem Inc エンドトキシンの除去方法
US5429746A (en) 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
DK0950067T3 (da) 1996-11-27 2007-12-27 Genentech Inc Affinitetsoprensning af polypeptid på protein A-matrix
US6489447B1 (en) 1998-05-06 2002-12-03 Genentech, Inc. Protein purification
PT1084136E (pt) 1998-06-01 2004-12-31 Genentech Inc Separacao de monomeros de anticorpos dos seus multimeros atraves da utilizacao de cromatografia de troca ionica
EP3088412B1 (en) 2001-03-09 2021-05-05 Chugai Seiyaku Kabushiki Kaisha Protein purification method
ES2321539T3 (es) 2001-06-05 2009-06-08 Genetics Institute, Llc Procedimientos relativos a la purificacion de proteinas altamente anionicas.
WO2003066662A2 (en) 2002-02-05 2003-08-14 Genentech, Inc. Protein purification
WO2004024752A1 (ja) 2002-09-11 2004-03-25 Chugai Seiyaku Kabushiki Kaisha タンパク質精製方法
CA2503284A1 (en) * 2002-10-24 2004-05-06 Enos Pharmaceuticals, Inc. Sustained release l-arginine formulations and methods of manufacture and use
AU2003298783B2 (en) * 2002-11-26 2010-11-04 Abbvie Biotherapeutics Inc. Chimeric and humanized antibodies to alpha5beta1 integrin that modulate angiogenesis
EA008038B1 (ru) * 2003-01-08 2007-02-27 Чирон Корпорейшн Стабилизированные водные композиции, содержащие ингибитор пути метаболизма, тканевого фактора (tfpi) или вариант ингибитора пути метаболизма тканевого фактора
EP1601697B1 (en) 2003-02-28 2007-05-30 Lonza Biologics plc Antibody purification by Protein A and ion exchange chromatography
GB0304576D0 (en) 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
BR122020007658B1 (pt) 2003-10-27 2021-07-27 Wyeth Método para a remoção de agregados de elevado peso molecular utilizando cromatografia de hidroxiapatita
US8084032B2 (en) 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
DE602006003108D1 (de) 2005-03-03 2008-11-27 Ajinomoto Kk Methode zur Verbesserung der Ausbeute bei der Proteinreinigung mittels Gelfiltrationschromatographie und Arginin
RU2457214C2 (ru) * 2005-03-11 2012-07-27 Вайет Способ хроматографии в режиме слабого распределения
EP1974215B1 (en) 2006-01-06 2017-12-27 EMD Millipore Corporation Affinity chromatography matrices and methods of making and using the same
US8263750B2 (en) 2006-03-16 2012-09-11 Amgen Inc. Method for purifying a protein using protein-A affinity chromatography using an intermediate wash step
CA2645739A1 (en) 2006-03-20 2007-09-27 Medarex, Inc. Protein purification
MX2008015263A (es) 2006-06-02 2008-12-17 Wyeth Corp Uso de proteinas y pepetidos de la superfamilia del factor beta transformador de crecimiento para purificacion y metodos terapeuticos.
US7754689B2 (en) * 2006-06-02 2010-07-13 Wyeth Llc Finger-1 peptide analogs of the TGF-β superfamily
PL2061803T5 (pl) 2006-08-28 2023-03-27 Ares Trading S.A. Proces oczyszczania białek zawierających fc
AU2007292253A1 (en) 2006-09-08 2008-03-13 Wyeth Arginine wash in protein purification using affinity chromatography
CA2673771A1 (en) 2007-01-17 2008-07-24 Merck Serono S.A. Process for the purification of fc-containing proteins
KR101226353B1 (ko) 2007-06-01 2013-01-24 에프. 호프만-라 로슈 아게 면역글로불린 정제
CN102027010A (zh) 2008-05-15 2011-04-20 诺沃-诺迪斯克有限公司 抗体纯化方法
EP2321338A1 (en) 2008-08-14 2011-05-18 Merck Sharp & Dohme Corp. Methods for purifying antibodies using protein a affinity chromatography
PL3272764T3 (pl) 2009-12-18 2024-06-10 Novartis Ag Sposób chromatografii powinowactwa
WO2012164046A1 (en) * 2011-06-01 2012-12-06 Novartis Ag Wash solution and method for affinity chromatography

Also Published As

Publication number Publication date
PT3272764T (pt) 2024-04-24
JP2016128495A (ja) 2016-07-14
BR112012014937A2 (pt) 2016-03-08
LT3272764T (lt) 2024-05-10
LT2513134T (lt) 2017-11-27
AU2010332778A1 (en) 2012-07-19
US20170044211A1 (en) 2017-02-16
EP2513134A1 (en) 2012-10-24
MX2012007103A (es) 2012-07-17
SG10201408384PA (en) 2015-01-29
KR101858266B1 (ko) 2018-05-15
CN102725304A (zh) 2012-10-10
PL2513134T3 (pl) 2018-02-28
ES2651065T3 (es) 2018-01-24
DK3272764T3 (da) 2024-05-06
BR112012014937B1 (pt) 2021-01-19
CA2784278A1 (en) 2011-06-23
US20120283416A1 (en) 2012-11-08
EP3272764A1 (en) 2018-01-24
WO2011073389A1 (en) 2011-06-23
RU2012130151A (ru) 2014-01-27
AU2010332778B2 (en) 2015-03-19
CA2784278C (en) 2019-02-26
RU2564569C2 (ru) 2015-10-10
ES2982297T3 (es) 2024-10-15
SG181771A1 (en) 2012-07-30
PL3272764T3 (pl) 2024-06-10
US20190233469A1 (en) 2019-08-01
KR20120109506A (ko) 2012-10-08
CN102725304B (zh) 2015-12-09
IL220164A0 (en) 2012-07-31
EP2513134B1 (en) 2017-09-06
DK2513134T3 (en) 2017-12-18
PT2513134T (pt) 2017-12-14
JP5909450B2 (ja) 2016-04-26
JP2013514073A (ja) 2013-04-25
EP3272764B1 (en) 2024-02-07
US9505803B2 (en) 2016-11-29

Similar Documents

Publication Publication Date Title
IL220164B (en) A method for purifying a purified antibody, antibody fragment, or fc-fused protein using an affinity chromatography matrix
AU2009282234A8 (en) Methods for purifying antibodies using protein A affinity chromatography
IL244157A0 (en) Isolation and purification of antibodies using protein a affinity chromatography
ZA201006150B (en) Purified immunoglobulin fusion proteins and methods of their purification
ZA201202720B (en) Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography
IL195191A (en) Digested Proteins, Nucleic Acids Encoded, and the Process of Creating
BRPI0918947A2 (pt) proteína de fusão de anticorpo
IL202128A0 (en) Immunoglobulin fusion proteins
WO2008157378A8 (en) Rage fusion proteins
BRPI0716139A2 (pt) processo para purificaÇço de proteÍnas de fusço fc
HK1206420A1 (en) Affinity reagants for protein purification
WO2010107752A3 (en) Alpha-4-beta-7 heterodimer specific antagonist antibody
EP2304440A4 (en) NEW MONOCLONAL ANTIBODIES AGAINST HPV PROTEINS
WO2007137984A3 (en) Modified humanised anti-interleukin-18 antibodies
WO2010117760A3 (en) Fusion proteins comprising canine fc portions
HUE042919T2 (hu) Genetikai immunizáció sejthez kapcsolódó antigének - például P2X7, CXCR7 vagy CXCR4 - elleni immunglobulinok elõállítására
WO2008048519A3 (en) Antibodies that bind cxcr7 epitopes
IL215538A0 (en) Antibody fusion proteins with modified fcrn binding sites
WO2009130459A3 (en) Epitopes of il-17a and il-17f and antibodies specific thereto
SG11201501597VA (en) Mix-mode antibody affinity separation matrix and purification method using same, and target molecule
WO2011055897A3 (en) Fusion protein binding specifically to constant region of antibody, preparation thereof and method for isolating antibody using the same
IL209888A (en) A method for detecting high affinity antibodies
BRPI0822347A2 (pt) método de produção de proteínas ou peptídeos heterólogos.
HK1175182A (en) Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography
AU2009900110A0 (en) Enhanced protein recovery method

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed